Introduction: Mental disorders are quite common in association with human immunodeficiency virus (HIV). Mental disorders are more prevalent in people living with HIV/AIDS (PLWHA) than the general population. The aim of this study was to evaluate depression, anxiety and insomnia in PLWHA and its correlation with socio-demographic factors and cluster of differentiation-4 (CD4) count. Material and methods:This was a cross sectional study conducted in Pt. BD Sharma PGIMS, Rohtak on 500 PLWHA in India. Hospital Anxiety and Depression Scale-Depression (HADS-D), Hospital Anxiety and Depression Scale-Anxiety (HADS-A) and Pittsburgh Sleep Quality Index (PSQI) scale were used to assess depression, anxiety and insomnia respectively in PLWHA. Five groups were designed on the basis of CD4 count: Group A (< 100 cells/μl), Group B (100-199 cells/μl), Group C (200-349 cells/μl), Group D (350-499 cells/μl) and Group E (> 500 cells/μl).Results: Prevalence of anxiety, depression and insomnia was found to be 59.6%, 61.2% and 56.4% respectively. Males had higher prevalence of depression and insomnia which are 64.2% and 57.4% respectively, whereas female had higher prevalence of anxiety (63%). There was a positive correlation between each score i.e. HADS-A, HADS-D and PSQI scale. There was a weak negative correlation between CD4 and each score.Conclusions: Despite higher prevalence, psychiatric illnesses remains underdiagnosed most of the time. Thus clinicians at the anti-retroviral therapy centre should screen these patients for depression, anxiety and depression for improvement in morbidity and mortality in PLWHA.
Background: Leukocytosis, predominantly neutrophilia has previously been described following ST elevation myocardial infarction (STEMI). The exact contribution of this phenomenon to the clinical outcome of STEMI is yet to be shown. We examined cellular inflammatory response to STEMI in the blood by assessing total neutrophil count (TNC), neutrophil to lymphocyte ratio (NLR) and Left ventricular ejection fraction (LVEF) post myocardial infarction and their association with inhospital mortality and/or adverse clinical events. Methods: In this cross-sectional study, 50 patients who were admitted with the diagnosis of acute STEMI at Government medical college and Hospital, Amritsar were studied. The complete blood cell count (CBC) was done in all patients within12-24 hours of the onset of symptoms. Total leukocyte count and differential leukocyte count were performed and neutrophil/lymphocyte ratio (NLR) was calculated. Left ventricular ejection fraction was assessed within one week of MI. Association of cellular response and ejection fraction with the incidence of post-MI mortality/complications like pulmonary edema, cardiogenic shock, arrhythmias and blocks were assessed by using ROC curve analysis and chi square test. Results: In-hospital mortality and post-STEMI complication rate were 8% and 42%, respectively. Total neutrophil count (P=0.029) and Neutrophil to lymphocyte ratio (P=0.001) were predictors of mortality. High NLR (P<0.001) and lower LVEF (P<0.001) were predictors of total complications and cardiogenic shock. Pump failure in the form of acute pulmonary edema (6%) or cardiogenic shock (8%) occurred in 7 (14%) patients. Higher total neutrophil counts (P=0.009), higher NLR (P<0.001) and lower ejection fraction (P<0.001) were predictors of pulmonary edema. The frequency of ventricular tachyarrhythmias (VT/VF) at the first day was associated with higher NLR level (P=0.029).High TNC and low LVEF were predictors for first degree heart block and high NLR was predictor for third degree heart bock and left bundle branch block. Conclusion: A single CBC analysis along with routinely assessed parameter i.e. ejection fraction may help to identify STEMI patients at risk for mortality and heart failure, while neutrophil to lymphocyte ratio is the most valuable in predicting both.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.